110 related articles for article (PubMed ID: 1313529)
21. Immunoassay with cytomegalovirus early antigens from gene products p52 and CM2 (UL44 and UL57) detects active infection in patients with chronic fatigue syndrome.
Beqaj SH; Lerner AM; Fitzgerald JT
J Clin Pathol; 2008 May; 61(5):623-6. PubMed ID: 18037660
[TBL] [Abstract][Full Text] [Related]
22. Cytomegalovirus antibodies in renal transplant recipients.
Jankowski M; Gut W; Nawrocka E; Gradowska L; Roncewicz Z; Rowińska D
Acta Microbiol Pol; 1982; 31(3-4):279-85. PubMed ID: 6189377
[TBL] [Abstract][Full Text] [Related]
23. Cytomegalovirus infection in liver transplant recipients.
Fan J; Ma WH; Qian J; Chen Z; Huang DS; Wang WL; Zheng SS
Hepatobiliary Pancreat Dis Int; 2002 Feb; 1(1):30-2. PubMed ID: 14607618
[TBL] [Abstract][Full Text] [Related]
24. [CMV antibody determination with two enzyme immunoassays in each case].
Albert S; Sibrowski W; Kühnl P; Knödler B; Seidl S; Böhm BO; Doerr HW
Beitr Infusionsther; 1990; 26():40-2. PubMed ID: 1703884
[TBL] [Abstract][Full Text] [Related]
25. Comparison of immunological reactivity to two major antigens of homologous and AD169 human cytomegalovirus strains during primary infection in renal transplant patients.
Rossier E; Miller H; Dal Monte P; Boccuni C; Landini MP
New Microbiol; 1993 Jan; 16(1):1-9. PubMed ID: 8385731
[TBL] [Abstract][Full Text] [Related]
26. Comparative immunoblot analysis with ten different, partially overlapping recombinant fusion proteins derived from five different cytomegalovirus proteins.
Van Zanten J; Lazzarotto T; Campisi B; Vornhagen R; Jahn G; Landini MP; The TH
New Microbiol; 1995 Apr; 18(2):223-8. PubMed ID: 7603351
[TBL] [Abstract][Full Text] [Related]
27. Anti-HCMV serologic response in patients with acute viral hepatitis.
Stivala A; Guglielmino SP; Scalia G; Condorelli F; Ursino F; Castro A; Mughini MT; Cosentino S; Russo R
New Microbiol; 1995 Oct; 18(4):423-6. PubMed ID: 8590395
[TBL] [Abstract][Full Text] [Related]
28. Cytomegalovirus-specific antibody responses in renal transplant patients with primary and recurrent CMV infections.
O'Neill HJ; Shirodaria PV; Connolly JH; Simpson DI; McGeown MG
J Med Virol; 1988 Apr; 24(4):461-70. PubMed ID: 2835436
[TBL] [Abstract][Full Text] [Related]
29. Kinetics of specific immunoglobulins M, E, A, and G in congenital, primary, and secondary cytomegalovirus infection studied by antibody-capture enzyme-linked immunosorbent assay.
Nielsen SL; Sørensen I; Andersen HK
J Clin Microbiol; 1988 Apr; 26(4):654-61. PubMed ID: 2835388
[TBL] [Abstract][Full Text] [Related]
30. Comparison of two Cobas Core enzyme immunoassays with other test systems for the detection of cytomegalovirus-specific IgG and IgM antibodies.
Steinmann J; Weigel T
J Clin Lab Anal; 1994; 8(4):191-9. PubMed ID: 7931812
[TBL] [Abstract][Full Text] [Related]
31. Virus-specific serum IgG, IgM, and IgA antibodies in cytomegalovirus mononucleosis patients as determined by immunoblotting technique.
Porath A; Hanuka N; Keynan A; Sarov I
J Med Virol; 1987 Jul; 22(3):223-30. PubMed ID: 3040895
[TBL] [Abstract][Full Text] [Related]
32. Pattern of anti-cytomegalovirus IgM antibodies determined by immunoblotting. A study of kidney graft recipients developing a primary or recurrent CMV infection.
Basson J; Tardy JC; Aymard M
Arch Virol; 1989; 108(3-4):259-70. PubMed ID: 2557810
[TBL] [Abstract][Full Text] [Related]
33. Localization of cytomegalovirus antigens in liver allografts over time.
Theise ND; Conn M; Thung SN
Hum Pathol; 1993 Jan; 24(1):103-8. PubMed ID: 8380273
[TBL] [Abstract][Full Text] [Related]
34. Antibody responses to human cytomegalovirus-specific polypeptides studied by immunoblotting in relation to viral load during cytomegalovirus infection.
van Zanten J; van der Giessen M; van Son WJ; The TH
J Med Virol; 1993 Jan; 39(1):80-7. PubMed ID: 8380844
[TBL] [Abstract][Full Text] [Related]
35. Antigenemia, immunoblotting, and enzyme immunoassay for early diagnosis of cytomegalovirus infection in renal transplant patients.
Fischer L; Rautenberg P; Bienengräber H; Leimenstoll G
Transpl Int; 1993; 6(4):201-5. PubMed ID: 8394090
[TBL] [Abstract][Full Text] [Related]
36. Significance of cytomegalovirus infection in the failure of native arteriovenous fistula.
Dzabic M; Bojakowski K; Kurzejamska E; Styczynski G; Andziak P; Söderberg-Nauclér C; Religa P
Clin Microbiol Infect; 2012 Jan; 18(1):E5-7. PubMed ID: 22070535
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis and monitoring of cytomegalovirus infection after liver transplantation in children.
Kaliciński P; Kamiński A; Prokurat A; Drewniak T; Chrupek M; Ochalska B; Dzierzanowska D; Szymczak M; Ismail H; Pawłowska J; Kamiński W
Ann Transplant; 1996; 1(2):13-4. PubMed ID: 9869923
[TBL] [Abstract][Full Text] [Related]
38. Cytomegalovirus-specific in vitro antibody production by peripheral blood lymphocytes from renal transplant recipients with CMV infection.
Segondy M; Barat L; Mourad G; Huguet MF; Serre A; Vendrell JP
J Med Virol; 1993 Jul; 40(3):200-3. PubMed ID: 8394872
[TBL] [Abstract][Full Text] [Related]
39. Clinical evaluation of a new recombinant antigen-based cytomegalovirus immunoglobulin M immunoassay in liver transplant recipients.
Halling VW; Maine GT; Groettum CM; Wilson JA; Spesard J; Brojanac S; Combs B; Wachta D; Holas C; Wilson T; Wang D; Tomazic-Allen S; Lazzarotto T; Landini MP; Jevremovic-Simovic S; Wiesner RH; Paya CV; Smith TF
Transplantation; 2001 Feb; 71(3):395-7. PubMed ID: 11233899
[TBL] [Abstract][Full Text] [Related]
40. Systemic antibody response to Clostridium difficile in colonized patients with and without symptoms and matched controls.
Sánchez-Hurtado K; Corretge M; Mutlu E; McIlhagger R; Starr JM; Poxton IR
J Med Microbiol; 2008 Jun; 57(Pt 6):717-724. PubMed ID: 18480328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
